Company News
12 Jul 2024
In this Q&A with Paul Kase, Lumos’ SVP, Commercial Operations, Paul outlines how Lumos is working in partnership with Henry Schein to access key global markets, and the imminent availability of FebriDx® to Australian healthcare practitioners as Australia enters its peak flu season.
Take a look:
A few more pieces along the same thread. See the full index for everything.
COMPANY NEWS
1 min read
MST Access has published a research report on Lumos Diagnostics Limited.
COMPANY NEWS
2 min read
Lumos Diagnostics has announced further progress in the U.S. commercialisation of FebriDx® across its priority top-100 urgent care target list.
COMPANY NEWS
1 min read
Lumos CEO Doug Ward, Lumos Chief Commercial Officer Paul Kase, Lumos Director of U.S. Sales